Grace Lin, M.D., M.B.A.

Professor of Medicine and Vice Chair of Circulatory Failure
Mayo Clinic

Fellowship Profile

Fellowship Year: 2023-2024
Fellowship Placement: Congressional Budget Office
Sponsoring Institution: Mayo Clinic Department of Cardiovascular Diseases


Grace Lin is a Professor of Medicine, advanced heart failure cardiologist and echocardiographer at Mayo Clinic. In her role as Vice Chair of the Division of Circulatory Failure at Mayo Clinic she oversees clinical operations and enterprise practice standardization for heart failure. Her clinical expertise and academic interests are focused on cardiac amyloidosis and cardio-oncology. She is committed to improving healthcare access for individuals with cardiovascular disease through practice innovations in healthcare delivery including digital health and remote monitoring as well as new models of community and home-based care.

Dr. Lin is a nationally recognized expert in cardiac amyloidosis and has served as a principal investigator in clinical trials for amyloid heart disease. She is the heart failure lead for the Mayo Echo Core Laboratory which directs imaging for multi-center heart failure clinical trials. Dr. Lin spearheaded a practice innovation to deliver in-home intermediate acuity care for acute decompensated heart failure as an alternative to hospitalization in partnership with the community paramedicine group. She has advised several startup companies developing digital health tools for heart failure management and directs the heart failure remote monitoring program at Mayo Clinic. She is a fellow of the American College of Cardiology and the American Society of Echocardiography.

Dr. Lin received her undergraduate degree with honors and special honors from the University of Chicago and an MD from the Loyola University Chicago Stritch School of Medicine. She completed internal medicine residency and cardiology training at Mayo Clinic, and is board certified in echocardiography, cardiovascular diseases, and advanced heart failure and transplant. In 2021, she received an MBA from the University of Chicago Booth School of Business, where her team was winner of the 2021 Global New Ventures Competition for their digital health innovation to remotely screen for valvular heart disease.